Genetic polymorphism at codon 10 of the transforming growth factor-β1 gene in patients with alcoholic liver cirrhosis
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: Transforming growth factor beta1 (TGF-β1) is a key cytokine in the production of extracellular matrix. A genetic polymorphism at codon 10 of the TGF-β1 gene is associated with liver fibrosis. We investigated the effect of genetic polymorphisms at codon 10 on the development of alcoholic liver cirrhosis (ALC). Methods: In total, 119 controls and 182 patients with ALC, were enrolled in the study. Clinical and laboratory data including total lifetime alcohol intake were collected at enrollment. The genotype at codon 10 was determined for each patient by single-strand conformation polymorphism. Results: There were three types of genetic polymorphism at codon 10: homozygous proline (P/P), heterozygous proline/leucine (P/L), and homozygous leucine (L/L). Among the controls, the proportions of P/P, P/L, and L/L were 26.1%, 44.5%, and 29.4%, respectively in the ALC group, these proportions were 23.1%, 43.4%, and 33.5%, respectively. The genotype distribution did not differ between the controls and the ALC group. In the ALC group, age, total lifetime alcohol intake, and distribution of Child-Pugh class did not differ with the genotype. Of the male patients with ALC (n=164), the proportions of P/P, P/L, and L/L were 20.1%, 44.5%, and 35.4%, respectively the genotype distribution did not differ between the male controls and the male ALC patients. Conclusions: The genotype at codon 10 in TGF-β1 does not appear to influence the development of ALC. Further study is needed to investigate other genetic factors that influence the development of ALC in patients with chronic alcohol intake.
Abstract
Background/Aims: Transforming growth factor beta1 (TGF-β1) is a key cytokine in the production of extracellular matrix. A genetic polymorphism at codon 10 of the TGF-β1 gene is associated with liver fibrosis. We investigated the effect of genetic polymorphisms at codon 10 on the development of alcoholic liver cirrhosis (ALC). Methods: In total, 119 controls and 182 patients with ALC, were enrolled in the study. Clinical and laboratory data including total lifetime alcohol intake were collected at enrollment. The genotype at codon 10 was determined for each patient by single-strand conformation polymorphism. Results: There were three types of genetic polymorphism at codon 10: homozygous proline (P/P), heterozygous proline/leucine (P/L), and homozygous leucine (L/L). Among the controls, the proportions of P/P, P/L, and L/L were 26.1%, 44.5%, and 29.4%, respectively in the ALC group, these proportions were 23.1%, 43.4%, and 33.5%, respectively. The genotype distribution did not differ between the controls and the ALC group. In the ALC group, age, total lifetime alcohol intake, and distribution of Child-Pugh class did not differ with the genotype. Of the male patients with ALC (n=164), the proportions of P/P, P/L, and L/L were 20.1%, 44.5%, and 35.4%, respectively the genotype distribution did not differ between the male controls and the male ALC patients. Conclusions: The genotype at codon 10 in TGF-β1 does not appear to influence the development of ALC. Further study is needed to investigate other genetic factors that influence the development of ALC in patients with chronic alcohol intake.
참고문헌 (33)
- Ministry of Health and Welfare, "2008 National Health Statistics-The Fourth Korean National Health and Nutrition Examination Survey (KNHANES Ⅳ-2)" (2009), Korea Centers for Disease Control and Prevention
- U. S. Department of Health and Human Services, "2009: with special feature on medical technology", pp.286~288 (2010), National Center for Health Statistics (US)
- Lee CH, "Perspectives of chronic liver disease in Korea. In: The Korean Socienty of Gastroenterology, ed. Hepatitis. 2nd ed", pp.1~2 (2005), Koonja
- Kim KA, "Current status of liver diseases in Korea: toxic and alcoholic liver diseases", Korean J Hepatol, 15(6), pp.29~33 (2009)
- Purohit V, "Mechanisms of alcohol-induced hepatic fibrosis: a summary of the Ron Thurman Symposium", Hepatology, 43, pp.872~878 (2006)
- Walsh K, "Alcoholic liver disease", Postgrad Med J, 76, pp.280~286 (2000)
- Műller C, "Liver, alcohol and gender", Wien Med Wochenschr, 156, pp.523~526 (2006)
- Branton MH, "TGF-beta and fibrosis", Microbes Infect, 1, pp.1349~1365 (1999)
- Oliver J, "Polymorphisms in the transforming growth factor-beta gene (TGF-beta) and the risk of advanced alcoholic liver disease", Liver Int, 25, pp.935~939 (2005)
- Awad MR, "Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation", Transplantation, 66, pp.1014~1020 (1998)
- Cambien F, "Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Témoin de l'Infarctus du Myocarde (ECTIM) Study", Hypertension, 28, pp.881~887 (1996)
- Powell EE, "Host genetic factors influence disease progression in chronic hepatitis C", Hepatology, 31, pp.828~833 (2000)
- Gewaltig J, "Association of polymorphisms of the transforming growth factorbeta1 gene with the rate of progression of HCV-induced liver fibrosis", Clin Chim Acta, 316, pp.83~94 (2002)
- Kwon OS, "Polymorphism in codons 10 and 25 of the transforming growth factorbeta1 gene in Korean population and in patients with liver cirrhosis and hepatocellular carcinoma", Korean J Gastroenterol, 42, pp.212~219 (2003)
- Zhang Y, "Genetic polymorphisms of transforming growth factor-beta1 and its receptors and colorectal cancer susceptibility: a population-based case-control study in China", Cancer Lett, 275, pp.102~108 (2009)
- Kikuchi K, "Genetic polymorphisms of transforming growth factor beta-1 promoter and primary biliary cirrhosis in Japanese patients", Ann N Y Acad Sci, 1110, pp.15~22 (2007)
- Blobe GC, "Role of transforming growth factor beta in human disease", N Engl J Med, 342, pp.1350~1358 (2000)
- Jakowlew SB, "Transforming growth factor-beta (TGF-beta) isoforms in rat liver regeneration: messenger RNA expression and activation of latent TGF-beta", Cell Regul, 2, pp.535~548 (1991)
- Bissell DM, "Transforming growth factor beta and the liver", Hepatology, 34, pp.859~867 (2001)
- McCullough AJ, "Alcoholic liver disease, In Schiff's Diseases of the Liver. Vol 2. 8th ed", pp.941~972 (1999), Lippincott-Raven
- Norton R, "Alcohol consumption and the risk of alcohol related cirrhosis in women", Br Med J, 295, pp.80~82 (1987)
- 유상균, "Influence of Transforming Growth Factor-b1 Gene Polymorphism at Codon 10 on the Development of Cirrhosis in Chronic Hepatitis B Virus Carriers", Journal of Korean Medical Science, 25(4), pp.564~569 (2010), 대한의학회
- Yamada Y, "Association of a polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women", J Bone Miner Res, 13, pp.1569~1576 (1998)
- Yamada Y, "Association of transforming growth factor beta1 genotype with spinal osteophytosis in Japanese women", Arthritis Rheum, 43, pp.452~460 (2000)
- Yokota M, "Association of a T29→C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese", Circulation, 101, pp.2783~2787 (2000)
- Wang H, "Transforming growth factor-beta1 gene polymorphisms are associated with progression of liver fibrosis in Caucasians with chronic hepatitis C infection", World J Gastroenterol, 11, pp.1929~1936 (2005)
- Suzuki S, "Transforming growth factor-beta-1 genetic polymorphism in Japanese patients with chronic hepatitis C virus infection", J Gastroenterol Hepatol, 18, pp.1139~1143 (2003)
- Migita K, "Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection--association between TGF-beta1 polymorphisms and hepatocellular carcinoma", J Hepatol, 42, pp.505~510 (2005)
- Bathgate AJ, "Polymorphisms in tumour necrosis factor alpha, interleukin-10 and transforming growth factor beta1 genes and end-stage liver disease", Eur J Gastroenterol Hepatol, 12, pp.1329~1333 (2000)
- Baraona E, "Gender differences in pharmacokinetics of alcohol", Alcohol Clin Exp Res, 25, pp.502~507 (2001)
- Seitz HK, "Human gastric alcohol dehydrogenase activity: effect of age, sex, and alcoholism", Gut, 34, pp.1433~1437 (1993)
- YoonJunKim, "Association of transforming growth factor-β1 gene polymorphisms with a hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection", Experimental and Molecular Medicine, 35(3), pp.196~202 (2003), 생화학분자생물학회
- Midanik L, "The validity of self-reported alcohol consumption and alcohol problems: a literature review", Br J Addict, 77, pp.357~382 (1982)